COVID-19 Vaccine Distribution the Next Supply Chain Frontier

An overview of various aspects of the supply chain that would be crucial in the production and distribution of COVID-19 Vaccine. Write to us at connect@pharmashots.com if you want a PDF copy of this report. Over the past seven months, the global pandemic caused by the spread of SARS-CoV-2, the virus that leads to coronavirus disease (COVID-19),…

BySenior EditorAugust 13, 2020

Announcements

PharmaShots Celebrates Successful Accomplishment of Two Years

Shots: PharmaShots started its journey in July 2018 as a concise news delivery service and is proud to announce the completion of two years, with many more to come. Till now, PharmaShots has published 3,057 posts delivered to our 3000+ subscribers On the 2nd anniversary, PharmaShots announced 'PharmaShots Bespoke' its new tailor-made, and targeted news…

BySenior EditorJuly 25, 2020

INSIGHTS+

PharmaShots’ Key Highlights of First Quarter 2020

The first quarter of 2020 includes big news regarding global companies. The highlight of the quarter is the acquisition of QIAGEN by ThermoFisher for ~$11.5B, Danaher's acquisition of the biopharma business of GE Life Sciences in an all-cash transaction for ~$21.4B. Numerous alliances are there which include Fosun's agreement with BioNTech to develop and commercialize…

BySenior EditorApril 8, 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in February 2020

The US FDA has approved multiple NDAs and BLAs in Feb 2020, leading to treatments for patients and advances in health care The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 13 novel products so far in 2020, including 10 in Feb and 3 in Jan…

BySenior EditorMarch 27, 2020

INSIGHTS+

PharmaShots’ Key Highlights of Fourth Quarter 2019

1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date - Oct 01, 2019 Product - Zirabev (biosimilar, bevacizumab) The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept 2019,…

BySenior EditorJanuary 24, 2020

INSIGHTS+

PharmaShots’ Key Highlights of Third Quarter 2019

The third quarter of 2019 has ended with major acquisitions in the pharma and biotech industry along with multiple approvals. Starting with the latest acquisition where Biocon Biologics acquires Pfizer's Research Facility for expansion of its R&D footprints with the acceleration of the development of its biosimilars from lab to pilot scale. Previously, Amgen acquired…

BySenior EditorSeptember 7, 2019

Announcements

PharmaShots Celebrates Successful Accomplishment of One Year

Shots: Team PharmaShots started their journey on 25 July 2018 and is proudly announcing their completion of one year, with many more to come. PharmaShots has published 1,238 news and articles till date We are grateful to all our subscribers for their affection towards PharmaShots and for subscribing our news alerts. We ensure to put…

BySenior EditorJuly 25, 2019

INSIGHTS+

PharmaShots’ Key Highlights of Second Quarter 2019

The second quarter of 2019 has ended with major acquisitions in pharma and biotech industry. Moving with the latest acquisition of Allergan for $63B by AbbVie focusing on to generate revenue with addition of Allergan's medical aesthetics and ophthalmology portfolio. Prior to that, Pfizer acquired Array Biopharma for $11.4B to expand its oncology portfolio. Some…

BySenior EditorJuly 3, 2019

Announcements

PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog

Shots: Team PharmaShots proudly announce that we are awarded as Top 50 Pharma Blog by Feedspot We are thankful to Feedspot for identifying our efforts and awarding us with this honor. We will continue to put our effort to provide the latest news available to our subscribers PharmaShots is a Digital News Media and Insights company that…

BySenior EditorMarch 13, 2019

COVID-19 Vaccine Distribution the Next Supply Chain Frontier

PharmaShots Celebrates Successful Accomplishment of Two Years

PharmaShots’ Key Highlights of First Quarter 2020

Insights+: The US FDA New Drug Approvals in February 2020

PharmaShots’ Key Highlights of Fourth Quarter 2019

PharmaShots’ Key Highlights of Third Quarter 2019

PharmaShots Celebrates Successful Accomplishment of One Year

PharmaShots’ Key Highlights of Second Quarter 2019

PharmaShots Awarded as Feedspot’s Top 50 Pharma Blog

Contact US

FOLLOW US